2BB score and signals
Heron Therapeutics, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 14 | Very Low |
| Momentum | 41 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 53 | Moderate |
Company facts
| Headquarters | San Diego, California, United States |
| Founded | 1983 |
| Employees | 128 |
| 52-week range | $0.30 – $1.58 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.0275 | — | $38.25M |
| 2026-08-10 | -0.03 | 0.0102 | $37.67M | $43.04M |
| 2026-05-11 | -0.04 | -0.0153 | $34.71M | $39.12M |
| 2026-02-26 | -0.02 | -0.0204 | $40.59M | $40.32M |
Related companies